Jeff Bernstein, based in San Francisco, CA, US, is currently a Co-Founder and CEO at Tegmine Therapeutics. Jeff Bernstein brings experience from previous roles at AbbVie Stemcentrx LLC, Stemcentrx, Inc. and Merck. Jeff Bernstein holds a 2002 - 2007 PhD in Biomedical Engineering, Metabolic Engineering @ UCLA. With a robust skill set that includes Monoclonal Antibodies, Protein Chemistry, Microbiology, Metabolic Engineering, Cell Culture and more. Jeff Bernstein has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Jeff Bernstein?
Find contact details for 700 million professionals.